LYNDON CAGAMPAN, M.D.
Physical Medicine & Rehabilitation Physician in DOVER, Delaware. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
LYNDON CAGAMPAN, M.D. filed 2,408 Medicare Part D claims in 2023 as a Physical Medicine & Rehabilitation Physician in DOVER, Delaware, prescribing 91% generic.
- 2K
- Part D claims, 2023
- 91%
- generic prescribing
- $78.45
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
LYNDON CAGAMPAN, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
2,408 Top 14% higher than 86% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
LYNDON CAGAMPAN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about LYNDON CAGAMPAN, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Delaware
How Physical Medicine & Rehabilitation Physician compares to other specialties among Delaware providers
Physical Medicine & Rehabilitation Physician share within Delaware
Physical Medicine & Rehabilitation Physician is one of the more visible NUCC categories in Delaware
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Physical Medicine & Rehabilitation Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Physical Medicine & Rehabilitation Physician ABMS/AOA estimate
Est. board-certified rate (Physical Medicine & Rehabilitation Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Physical Medicine & Rehabilitation Physician US NPIs
Specialty board-certified rate — Physical Medicine & Rehabilitation Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
LYNDON CAGAMPAN, M.D. appears in the CMS NPPES registry as a Physical Medicine & Rehabilitation Physician provider holding M.D. credentials at 200 BANNING ST, DOVER, DE, 19904, with a listed phone of (302) 730-8848. NPI 1003842436 was issued on 06/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CAGAMPAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,408 prescription claims written by this provider, covering 147 Medicare beneficiaries and totaling roughly $224K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 59.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Physical Medicine & Rehabilitation Physician is a mid-sized specialty nationwide, with 15,306 enrolled providers across 54 states and an average of 781 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1003842436 |
|---|---|
| Specialty | Physical Medicine & Rehabilitation Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/25/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm LYNDON CAGAMPAN, M.D.'s current license status, disciplinary history, and board certifications with the Delaware Board of Medical Licensure in Delaware before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LYNDON CAGAMPAN, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$78
Largest payer
SCILEX PHARMACEUTICALS INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 2,408 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,531
- Total Day Supply
- 67,126
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $168K
- Generic Drug Cost
- $56K
- Opioid Claims
- 1,434 (59.6% rate)
Patient Demographics
- Average Patient Age
- 66.1 years
- Avg HCC Risk Score
- 1.71
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 58, 65-74: 68, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What LYNDON CAGAMPAN, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Oxycodone Hcl
Oxycodone Hcl
366 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
345 claims
- Tizanidine Hcl
Tizanidine Hcl
216 claims
- Morphine Sulfate Er
Morphine Sulfate Er
159 claims
- Tramadol Hcl 137
Tramadol Hcl
137 claims
- Gabapentin 129
Gabapentin
129 claims
- Hydrocodone-Acetam… 105
Hydrocodone-Acetaminophen
105 claims
- Cyclobenzaprine Hcl 70
Cyclobenzaprine Hcl
70 claims
| Drug | Claims |
|---|---|
| Oxycodone Hcl | 366 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 345 |
| Tizanidine Hcl | 216 |
| Morphine Sulfate Er Morphine Sulfate | 159 |
| Tramadol Hcl | 137 |
| Gabapentin | 129 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 105 |
| Cyclobenzaprine Hcl | 70 |
| Pregabalin | 61 |
| Duloxetine Hcl | 57 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Physical Medicine & Rehabilitation Physician Overview
How LYNDON CAGAMPAN, M.D. fits within the Physical Medicine & Rehabilitation Physician landscape nationally.
LYNDON CAGAMPAN, M.D.'s 2,408 claims are above the specialty average of 781.
Nearby Physical Medicine & Rehabilitation Physician Providers in Delaware
Other clinicians with the same primary specialty enrolled in Delaware, drawn from the same CMS NPPES roster as CAGAMPAN.
Compare Physical Medicine & Rehabilitation Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Delaware
Frequently Asked Questions
What is LYNDON CAGAMPAN, M.D.'s specialty? ▼
How much does LYNDON CAGAMPAN, M.D. prescribe under Medicare Part D? ▼
Where is LYNDON CAGAMPAN, M.D. located? ▼
What is LYNDON CAGAMPAN, M.D.'s NPI number? ▼
Does LYNDON CAGAMPAN, M.D. prescribe more brand-name or generic drugs? ▼
Does LYNDON CAGAMPAN, M.D. prescribe opioids? ▼
How many Physical Medicine & Rehabilitation Physician providers are there in the US? ▼
What drugs does LYNDON CAGAMPAN, M.D. prescribe most often? ▼
Does LYNDON CAGAMPAN, M.D. accept Medicare? ▼
How can I verify LYNDON CAGAMPAN, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology